Po Yee Mak

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance

Rodrigo Jácamo, Ye Chen, Zhiqiang Wang et al. · Blood · 2014 · 272 citations · Full text

Medicine, Cancer Biology, Oncology +14

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells

Bing Z. Carter, Po Yee Mak, Hong Mu et al. · Science Translational Medicine · 2016 · 169 citations

Medicine, Cell Biology, Oncology +17

Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition

Bing Z. Carter, Po Yee Mak, Wenjing Tao et al. · Haematologica · 2020 · 123 citations · Full text

Medicine, Oncology, Pharmacology +17

Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo

Hongsheng Zhou, Po Yee Mak, Hong Mu et al. · Leukemia · 2017 · 96 citations

Medicine, Cancer Biology, Oncology +12

Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i> -Mutant Acute Myeloid Leukemia

Xuejie Jiang, Po Yee Mak, Hong Mu et al. · Clinical Cancer Research · 2018 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17